Loading...

Pharvaris N.V.

PHVS•NASDAQ
Healthcare
Biotechnology
$29.14
$0.46(1.60%)
U.S. Market opens in 10h 57m

Pharvaris N.V. (PHVS) Stock Overview

Explore Pharvaris N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E Ratio-8.20
EPS (TTM)$-3.46
ROE-0.71%
Fundamental Analysis

AI Price Forecasts

1 Month$23.83
3 Months$27.29
1 Year Target$27.81

PHVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pharvaris N.V. (PHVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $27.81.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.20 and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.60%
5-Day Change
7.49%
1-Month Change
14.63%
3-Month Change
13.61%
6-Month Change
33.79%
Year-to-Date (YTD) Change
5.009%
1-Year Change
109.04%
3-Year Change
246.90%
5-Year Change
3.81%
All-Time (Max) Change
0.48%

Contact Information

https://pharvaris.com
31 71 203 6410
J.H. Oortweg 21, Leiden, NaN, 2333 CH

Company Facts

108 Employees
IPO DateFeb 5, 2021
CountryNL
Actively Trading

Frequently Asked Questions